Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DEB - Dystrophic Epidermolysis Bullosa”

70 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 70 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06892639
What this trial is testing

Evaluation of D-Fi for the Treatment of Wounds Due to DEB

Who this might be right for
Dystrophic Epidermolysis Bullosa
Castle Creek Biosciences, LLC. 32
Not applicableLooking for participantsNCT01019148
What this trial is testing

Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 70
Testing effectiveness (Phase 2)Looking for participantsNCT04173650
What this trial is testing

MSC EVs in Dystrophic Epidermolysis Bullosa

Who this might be right for
Dystrophic Epidermolysis Bullosa
Aegle Therapeutics 8
Large-scale testing (Phase 3)Active Not RecruitingNCT04213261
What this trial is testing

FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Castle Creek Biosciences, LLC. 6
Not applicableStudy completedNCT01716169
What this trial is testing

Treatment of Chronic and Non-Chronic Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa Using Helicoll Collagen Dressings Versus Standard of Care

Who this might be right for
Epidermolysis Bullosa DystrophicaEpidermolysis Bullosa
Stanford University 10
Large-scale testing (Phase 3)Study completedNCT03928093
What this trial is testing

Pregabalin Treatment for RDEB Pain and Itch

Who this might be right for
Pain, NeuropathicItchEpidermolysis Bullosa
The Hospital for Sick Children 1
Not applicableLooking for participantsNCT07700966
What this trial is testing

A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Abeona Therapeutics, Inc 250
Not applicableNot Yet RecruitingNCT07684105
What this trial is testing

Treatment of Dysphagia in Patients With Dystrophic Epidermolysis Bullosa With Budesonide: a Retrospective Bicentric Study Nice - Paris St Louis / Necker (EBUDE Study)

Who this might be right for
Recessive Dystrophic Epidermolysis BullosaDysphagiaEsophageal Stenosis
Centre Hospitalier Universitaire de Nice 15
Not applicableLooking for participantsNCT04917887
What this trial is testing

Long-Term Follow-up Protocol

Who this might be right for
Dystrophic Epidermolysis BullosaRecessive Dystrophic Epidermolysis BullosaDominant Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 50
Large-scale testing (Phase 3)Ended earlyNCT00587223
What this trial is testing

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica
Organogenesis 1
Very early researchActive Not RecruitingNCT04171661
What this trial is testing

Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
CHU de Quebec-Universite Laval 1
Not applicableStudy completedNCT01874769
What this trial is testing

Study of Immune Tolerance and Capacity for Wound Healing of Patients With Recessive Dystrophic Epidermolysis Bullosa (RDEB)

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
Institut National de la Santé Et de la Recherche Médicale, France 30
Testing effectiveness (Phase 2)UnknownNCT05529134
What this trial is testing

Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene

Who this might be right for
Dystrophic Epidermolysis Bullosa
Phoenicis Therapeutics 8
Testing effectiveness (Phase 2)Study completedNCT03786237
What this trial is testing

Rigosertib for RDEB-SCC

Who this might be right for
Epidermolysis Bullosa DystrophicaSquamous Cell Carcinoma
Prof. Johann Bauer 2
Testing effectiveness (Phase 2)Study completedNCT03536143
What this trial is testing

A Phase I/II Study of KB103, a Topical HSV1-COL7, on DEB Patients

Who this might be right for
Dystrophic Epidermolysis Bullosa
Krystal Biotech, Inc. 12
Not applicableStudy completedNCT00904163
What this trial is testing

Characteristics of Adult Patients With Recessive Dystrophic Epidermolysis Bullosa

Who this might be right for
Epidermolysis Bullosa Dystrophica
Stanford University 13
Not applicableStudy completedNCT03183934
What this trial is testing

A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 2
Not applicableStudy completedNCT04757727
What this trial is testing

Gynecological Follow-up of Patients With Dystrophic Epidermolysis Bullosa (EBD)

Who this might be right for
Dystrophic Epidermolysis Bullosa
Centre Hospitalier Universitaire de Nice 27
Early research (Phase 1)Study completedNCT03472287
What this trial is testing

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

Who this might be right for
Epidermolysis Bullosa (EB)Epidermolysis Bullosa SimplexDystrophic Epidermolysis Bullosa+1 more
Castle Creek Pharmaceuticals, LLC 11
Testing effectiveness (Phase 2)Study completedNCT03529877
What this trial is testing

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

Who this might be right for
Recessive Dystrophic Epidermolysis Bullosa
RHEACELL GmbH & Co. KG 16
Next Page